Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial comparing SH-1028 tablets to gefitinib in locally advanced or metastatic non-small cell lung cancer is in progress,…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating PD-1 monoclonal antibody SHR-1210 in combination with apatinib for advanced non-small cell lung cancer, so…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Anticancer Activity of Nicotinamide on Lung Cancer [Phase 2, Phase 3]
A clinical trial update reports anticancer activity of nicotinamide in non-small cell lung carcinoma across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating PET-adjusted intensity-modulated radiation therapy with combination chemotherapy in stage II-IV non-small cell lung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update for the BATTLE program evaluating Tarceva and Targretin in patients with advanced non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer [Phase 1]
Phase 1 feasibility trial evaluating navigational bronchoscopy-guided photodynamic therapy with Photofrin in unresectable peripheral lung ca…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: OMEGA, Local Ablative Therapy in Oligometastatic NSCLC [Phase 3]
Phase 3 trial evaluating local ablative therapy (OMEGA) in oligometastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations
Clinical trial update for GIOTRIF in first-line therapy of advanced non-small cell lung cancer with EGFR mutations; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement [Phase 2]
Phase 2 clinical trial update for X-396 capsule in advanced non-small cell lung cancer with ROS1 gene rearrangement.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating anlotinib in combination with docetaxel for EGFR wild-type advanced non-small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 1, Phase 2]
Clinical trial update on rociletinib (CO-1686) in previously treated EGFR-mutant NSCLC; study phases 1/2 terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC [Phase 1, Phase 2]
Clinical trial update for MTD study of PXD-101 in combination with paclitaxel and carboplatin in chemotherapy-naive patients with Stage IV n…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Metformin in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial of metformin in non small cell lung cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sintilimab in combination with bevacizumab for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial investigating dacomitinib combined with pemetrexed in advanced non-squamous non-small cell lung cancer has been terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: OSI-774 (Erlotinib, Tarceva) in Elderly Patients [Phase 2]
Phase 2 trial evaluating erlotinib (OSI-774, Tarceva) in elderly patients with non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC [Phase 2]
A Phase 2 trial evaluating antroquinonol for non-small cell lung cancer (Stage IV) has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 trial evaluating erlotinib with or without bevacizumab in stage IV non-small cell lung cancer with EGFR mutations has completed, wit…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating the combination of anlotinib with nivolumab for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Ponatinib in Advanced NSCLC w/ RET Translocations [Phase 2]
Phase 2 trial of ponatinib in advanced non-small cell lung cancer with RET translocations has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update of erlotinib in locally advanced or metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain [Phase 2]
Phase 2 trial update of abemaciclib in participants with brain-metastatic breast cancer, non-small cell lung cancer, or melanoma; study comp…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial evaluating a combination therapy of autologous dendritic cells pulsed with antigen peptides plus nivolumab in advanced non-…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating bortezomib with or without docetaxel in relapsed or refractory advanced non-small cell lung cancer has com…